Cancer treatments have evolved significantly, with oral medications becoming an integral part of modern cancer therapy. However, many insurance plans still classify oral medications differently, leading to higher out-of-pocket expenses for patients. This financial burden can prevent patients from adhering to their prescribed treatment plans, potentially affecting their prognosis. The Cancer Drug Parity Act aims to eliminate these financial barriers, ensuring that patients can access the most appropriate treatments without financial strain.
